No difference in the outcome of metastatic thyroid cancer patients when using recombinant or endogenous TSH.
Campopiano MC, Podestà D, Bianchi F, Giani C, Agate L, Bottici V, Cappagli V, Lorusso L, Matrone A, Puleo L, Valerio L, Viola D, Piaggi P, Elisei R, Molinaro E.
Campopiano MC, et al. Among authors: bianchi f.
Eur J Endocrinol. 2020 Oct;183(4):411-417. doi: 10.1530/EJE-20-0088.
Eur J Endocrinol. 2020.
PMID: 32688334